Literature DB >> 31497440

Brain Metastasis in a Young Patient with Uterine Carcinosarcoma.

Vatsala Katiyar1, Tiago Araujo1, Muhammad Z Farooq1, Ishaan Vohra1, Shweta Gupta2.   

Abstract

Uterine carcinosarcoma occurs almost exclusively in post-menopausal women and often carries high rates of disease recurrence and mortality. Central nervous system involvement is extremely rare with less than 10 reported cases in the literature. Here we present a young pre-menopausal patient with metastatic malignant mixed Mullerian tumor who developed cerebral metastasis while on systemic chemotherapy.

Entities:  

Keywords:  cerebral metasatasis; cns metastasis; endometrial cancer; malignant mixed mullerian tumor; mmmt; uterine carcinosarcoma

Year:  2019        PMID： 31497440      PMCID： PMC6713238          DOI： 10.7759/cureus.5010

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  13 in total

1.  The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.

Authors:  Edward J Tanner; Mario M Leitao; Karuna Garg; Dennis S Chi; Yukio Sonoda; Ginger J Gardner; Richard R Barakat; Elizabeth L Jewell
Journal:  Gynecol Oncol       Date:  2011-09-25       Impact factor: 5.482

Review 2.  Management of brain metastases.

Authors:  Kristin A Bradley; Minesh P Mehta
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

Review 3.  Review literature on uterine carcinosarcoma.

Authors:  Rajendra Singh
Journal:  J Cancer Res Ther       Date:  2014 Jul-Sep       Impact factor: 1.805

Review 4.  Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.

Authors:  Chirag G Patil; Katie Pricola; J Manuel Sarmiento; Sachin K Garg; Andrew Bryant; Keith L Black
Journal:  Cochrane Database Syst Rev       Date:  2017-09-25

5.  The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study.

Authors:  P Bitterman; B Chun; R J Kurman
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

Review 6.  Uterine carcinosarcoma: A review of the literature.

Authors:  Leigh A Cantrell; Stephanie V Blank; Linda R Duska
Journal:  Gynecol Oncol       Date:  2015-03-21       Impact factor: 5.482

7.  Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.

Authors:  Howard D Homesley; Virginia Filiaci; Maurie Markman; Pincas Bitterman; Lynne Eaton; Larry C Kilgore; Bradley J Monk; Frederick R Ueland
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

8.  Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.

Authors:  Nisha Bansal; Thomas J Herzog; Venkatraman E Seshan; Peter B Schiff; William M Burke; Carmel J Cohen; Jason D Wright
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

9.  Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.

Authors:  Michael Callister; Lois M Ramondetta; Anuja Jhingran; Thomas W Burke; Patricia J Eifel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

Review 10.  Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review.

Authors:  Neville F Hacker; Archana Rao
Journal:  Gynecol Oncol Res Pract       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.